EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 162 filers reported holding EAGLE PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $306,000 | -9.2% | 6,015 | -0.5% | 0.00% | – |
| Q3 2021 | $337,000 | +38.7% | 6,046 | +6.3% | 0.00% | – |
| Q2 2021 | $243,000 | +2.5% | 5,686 | 0.0% | 0.00% | – |
| Q1 2021 | $237,000 | -20.5% | 5,686 | -11.2% | 0.00% | – |
| Q4 2020 | $298,000 | +2.8% | 6,406 | -6.1% | 0.00% | – |
| Q3 2020 | $290,000 | -16.4% | 6,819 | -5.7% | 0.00% | – |
| Q2 2020 | $347,000 | -83.8% | 7,235 | -74.4% | 0.00% | -100.0% |
| Q2 2018 | $2,141,000 | -69.7% | 28,300 | -78.9% | 0.00% | -71.4% |
| Q1 2018 | $7,061,000 | -1.1% | 134,022 | +0.3% | 0.01% | +16.7% |
| Q4 2017 | $7,138,000 | -5.2% | 133,612 | +5.8% | 0.01% | -14.3% |
| Q3 2017 | $7,530,000 | -35.6% | 126,252 | -14.8% | 0.01% | -36.4% |
| Q2 2017 | $11,686,000 | -14.2% | 148,176 | -9.8% | 0.01% | -15.4% |
| Q1 2017 | $13,621,000 | +68.3% | 164,259 | +61.0% | 0.01% | +85.7% |
| Q4 2016 | $8,095,000 | +6.6% | 102,036 | -6.0% | 0.01% | 0.0% |
| Q3 2016 | $7,595,000 | +38.6% | 108,508 | -23.2% | 0.01% | +16.7% |
| Q2 2016 | $5,481,000 | -49.2% | 141,285 | -47.0% | 0.01% | -50.0% |
| Q1 2016 | $10,788,000 | -58.7% | 266,347 | -9.6% | 0.01% | -60.0% |
| Q4 2015 | $26,148,000 | -0.9% | 294,771 | -17.3% | 0.03% | -3.2% |
| Q3 2015 | $26,395,000 | -0.6% | 356,555 | +8.6% | 0.03% | +10.7% |
| Q2 2015 | $26,559,000 | +116.5% | 328,456 | +12.1% | 0.03% | +100.0% |
| Q1 2015 | $12,269,000 | +447.2% | 292,877 | +102.5% | 0.01% | +600.0% |
| Q4 2014 | $2,242,000 | +21.3% | 144,624 | -1.0% | 0.00% | 0.0% |
| Q3 2014 | $1,848,000 | +4.8% | 146,099 | +18.7% | 0.00% | 0.0% |
| Q2 2014 | $1,763,000 | +9.8% | 123,044 | -2.3% | 0.00% | 0.0% |
| Q1 2014 | $1,606,000 | – | 125,940 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JW Asset Management, LLC | 475,755 | $25,068,000 | 24.71% |
| Hudson Executive Capital LP | 971,000 | $51,162,000 | 15.09% |
| Park West Asset Management LLC | 1,051,274 | $55,392,000 | 2.47% |
| U S GLOBAL INVESTORS INC | 19,200 | $1,012,000 | 0.62% |
| Capital Impact Advisors, LLC | 26,317 | $1,387,000 | 0.57% |
| CLARK ESTATES INC/NY | 56,278 | $2,965,000 | 0.47% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 873,131 | $46,005,000 | 0.41% |
| ProQuest Associates IV LLC | 6,777 | $357,000 | 0.41% |
| Granite Investment Partners, LLC | 114,207 | $6,017,000 | 0.40% |
| GLOBEFLEX CAPITAL L P | 30,900 | $1,628,000 | 0.34% |